Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
05/2012
05/17/2012US20120121687 Wound healing material and method for fabricating the same
05/17/2012US20120121686 Biodegradable compositions having pressure sensitive adhesive properties
05/17/2012US20120121685 Breakfast cereals containing probiotic micro organisms
05/17/2012US20120121684 Coating Comprising A Poly(Ethylene Glycol)-Poly(Lactide-Glycolide-Caprolactone) Interpenetrating Network
05/17/2012US20120121683 Functional nanoparticle filled nanotubes and methods of their production
05/17/2012US20120121682 cRGD PEPTIDE DERIVATIVE AND ITS MANUFACTURE, AND IMPLANT HAVING A COATING CONTAINING A cRGD PEPTIDE DERIVATIVE
05/17/2012US20120121676 Method for manufacturing capsules, resulting capsules, and use of said capsules
05/17/2012US20120121675 Compounds which inhibit muscle contraction
05/17/2012US20120121674 Nonwoven fabric products with enhanced transfer properties
05/17/2012US20120121670 Polyarginine nanocapsules
05/17/2012US20120121668 Compositions for oral adminstration of active principles requiring masking of taste
05/17/2012US20120121667 Pharmaceutical Composition
05/17/2012US20120121666 Compositions of particles
05/17/2012US20120121665 Implantable or insertable medical device resistant to microbial growth and biofilm formation
05/17/2012US20120121664 Gastric Acid Secretion Inhibiting Composition
05/17/2012US20120121663 Treatment using dantrolene
05/17/2012US20120121662 Treatment using dantrolene
05/17/2012US20120121661 Devices with multiple surface functionality
05/17/2012US20120121660 Bone void fillers
05/17/2012US20120121659 Functionalized rgd peptidomimetics and their manufacture, and implant having a coating containing such functionalized rgd peptidomimetics
05/17/2012US20120121658 Functionalized rgd peptidomimetics and their manufacture, and implant having a coating containing such functionalized rgd peptidomimetics
05/17/2012US20120121657 Enhancing biocompatibility of a medical device
05/17/2012US20120121656 Methods and compositions for protecting against neurotoxicity of a neurotoxic agent, and improving motor coordination associated with a neurodegenerative condition or disease
05/17/2012US20120121655 Chewable Formulation Comprising Alginate, Bicarbonate And Carbonate
05/17/2012US20120121654 Nanoparticle isoflavone compositions & methods of making and using the same
05/17/2012US20120121653 Novel mometasone compositions and methods of making and using the same
05/17/2012US20120121622 Biodegradable immunomodulatory formulations and methods for use thereof
05/17/2012US20120121601 Mammalian receptor proteins; related reagents and methods
05/17/2012US20120121566 Solubilized CoQ-10
05/17/2012US20120121520 Functional formulation in chewing gum
05/17/2012US20120121516 Emulsion Activatable by Ultrasounds and Method for Producing Same
05/16/2012EP2452891A2 Complementary personal lubricant compositions and delivery system
05/16/2012EP2452797A2 Device and method for producing therapeutic foam
05/16/2012EP2452692A1 Treatment of autoimmune disorders with a neurotoxin
05/16/2012EP2452685A1 Buffered compositions for dialysis
05/16/2012EP2452684A2 Micelles
05/16/2012EP2452681A1 Salts of 13a-(s)desoxytylophorinine, preparation methods and pharmaceutical compositions and uses thereof
05/16/2012EP2452678A2 Pulsatile-release pharmaceutical formulation of dexlansoprazole
05/16/2012EP2452677A1 Extended release dosage form of ropinirole
05/16/2012EP2452676A1 Hydrogel comprising deuterium oxide for treating herpesvirus-based inflammations of the skin
05/16/2012EP2452675A1 Buccal spray containing sildenafil
05/16/2012EP2452673A2 Chitosan gel for dermatological use, production method therefor and use of same
05/16/2012EP2452672A2 Inhalable aztreonam lysinate formulation for treatment and prevention of pulmonary bacterial infections
05/16/2012EP2452671A2 Topical Pharmaceutical Formulation
05/16/2012EP2452670A1 Conveniently implantable sustained release drug compositions
05/16/2012EP2452669A1 Ophthalmic composition
05/16/2012EP2452577A1 Aqueous solution of phytin and use of said solution for preparing a liquid food supplement or a cosmetic composition
05/16/2012EP2452561A1 Material, item and products comprising a composition having anti-microbial properties
05/16/2012EP2452559A1 Material, item and products comprising a composition having anti-microbial properties
05/16/2012EP2452199A1 Solubilisation of membrane proteins
05/16/2012EP2451588A1 Substrate impregnated with sprayed clay, and method for manufacturing same
05/16/2012EP2451485A1 Lipidic compositions for induction of immune tolerance
05/16/2012EP2451472A1 Heat- and vibration-stable insulin preparations
05/16/2012EP2451458A2 Pharmaceutical compositions and solid forms
05/16/2012EP2451448A2 Crosslinked protein nanocrystals, crosslinked protein nanoaggregates and method of preparation thereof
05/16/2012EP2451447A2 Tableting agent having a low water content, and method for the production thereof
05/16/2012EP2451446A2 Composition for the production of tablets, and method for the production of said composition
05/16/2012EP2451445A2 Process for drying of bibw2992, of its salts and of solid pharmaceutical formulations comprising this active ingredient
05/16/2012EP2451444A1 Formulations of 6- (5-chloro-2-pyridyl) - 5- [ (4-methyl-1-piperazinyl) carbonyloxy]- 7-0x0-6, 7- dihydro- 5h- phyrrolo [3, 4-b]pyrazine
05/16/2012EP2451443A1 Method of drug delivery
05/16/2012EP2451442A1 Matrix carrier compositions, methods and uses
05/16/2012EP2451441A2 Mixture of amphipathic molecules and method for modifying cell membranes by means of fusion
05/16/2012EP2451440A1 Amphoteric liposomes comprising imino lipids
05/16/2012EP2451439A1 Composition comprising bioactive amino acids and/or peptides and marine oil in a stable oil-in-water emulsion, and the use of said composition as a functional or therapeutic composition
05/16/2012EP2451438A2 Pharmaceutical composition for a hepatitis c viral protease inhibitor
05/16/2012EP2451437A2 Aqueous preparations comprising methionine
05/16/2012EP2451436A1 Method and pharmaceutical compositions for trans-buccal mucosa treatment of postprandial hyperglycaemia in type ii diabetes
05/16/2012EP2451435A1 Sodium thiosulfate-containing pharmaceutical compositions
05/16/2012EP2451284A1 Novel gold-based nanocrystals for medical treatments and electrochemical manufacturing processes therefor
05/16/2012EP2451276A1 Methods of treating pdnv and ponv with extended release ondansetron compositions
05/16/2012EP2371352A9 Devices including protein matrix materials and methods of making and using thereof
05/16/2012EP2285214B1 Rasagiline soft gelatin capsules
05/16/2012EP2244693B1 Agent for intra-articular injection
05/16/2012EP2219643B1 Anthelmintic paste comprising praziquantel, a macrolide lactone, cyclodextrin and a thickener
05/16/2012EP2136790B1 Preparation for the controlled release of bioactive natural substances
05/16/2012EP2059206B1 Dry wound dressing and drug delivery system
05/16/2012EP1874726B1 Organic compounds
05/16/2012EP1861075B1 Coated granular formulations
05/16/2012EP1858487B1 Chemically defined stabiliser composition
05/16/2012CN202218984U Magnetic therapy paste with traditional Chinese medicine liquid
05/16/2012CN1946379B Prolonged-release compositions comprising torasemide and a matrix-forming polymer
05/16/2012CN102459351A 多糖类衍生物及其水凝胶 Polysaccharide derivatives and hydrogels
05/16/2012CN102458640A Multi-phase microparticles and method of manufacturing multi-phase microparticles
05/16/2012CN102458567A 螯合药剂的透皮离子电渗递送方法 Ion chelating agents transdermal delivery method infiltration
05/16/2012CN102458475A Dry-coated orally-disintegrating tablet
05/16/2012CN102458473A Method for treating or ameliorating mucocutaneous or ocular toxicities
05/16/2012CN102458423A 胶原产生促进剂 Collagen production promoting agent
05/16/2012CN102458409A Therapeutic applications in the cardiovascular field of quinazolinedione derivatives
05/16/2012CN102458406A Oral liquid preparation
05/16/2012CN102458397A Pharmaceutical composition comprising rotigotine salts (acid or na), especially for iontophoresis
05/16/2012CN102458388A Semi-solid compositions and pharmaceutical products
05/16/2012CN102458384A Stable topical compositions for 1,2,4-thiadiazole derivatives
05/16/2012CN102458382A Oil-in-water emulsion of mometasone and propylene glycol
05/16/2012CN102458380A Agglomerate formulations including active pharmaceutical agents with targeted particle sizes
05/16/2012CN102458379A Functional amphiphilic molecule or macromolecule formulations with multiple compartments
05/16/2012CN102458378A Process for the preparation of colloidal systems for the delivery of active compounds
05/16/2012CN102458377A Device and method for adjusting basal delivery profile
05/16/2012CN102458376A Combination of dopamine agonists plus first phase insulin secretagouges for treatment of metabolic disorders
05/16/2012CN102458375A Burst drug release compositions
05/16/2012CN102458374A Dermal delivery compositions comprising active agent-calcium phosphate particle complexes and methods of using the same
1 ... 515 516 517 518 519 520 521 522 523 524 525 526 527 528 529 530 531 532 533 534 535 ... 2991